Related Experiment Videos

A gene expression database for the molecular pharmacology of cancer

U Scherf1, D T Ross, M Waltham

  • 1Laboratory of Molecular Pharmacology, Division of Basic Sciences, Building 37/5D-02, National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, Maryland, USA.

Nature Genetics
|March 4, 2000
PubMed

Insights

Researchers linked gene expression and drug activity in 60 cancer cell lines. Gene expression clustering differed from drug response clustering, revealing gene-drug relationships for cancer drug discovery.

Area of Science:

  • Genomics
  • Pharmacology
  • Bioinformatics

Background:

  • The National Cancer Institute's NCI60 cell line panel is a standard resource for cancer drug discovery.
  • Understanding the relationship between gene expression and drug response is crucial for personalized medicine and drug development.

Purpose of the Study:

  • To integrate gene expression data with drug activity profiles for the NCI60 cancer cell lines.
  • To explore the correlation between gene expression patterns and cellular responses to various drugs.
  • To identify specific gene-drug relationships that can inform cancer therapy.

Main Methods:

  • Utilized cDNA microarrays to generate gene expression profiles for 60 human cancer cell lines.
  • Employed bioinformatics and chemoinformatics approaches to correlate gene expression data with drug activity patterns.
  • Applied clustering algorithms to analyze cell line relationships based on both gene expression and drug response.

Main Results:

  • Clustering of cell lines based on gene expression revealed distinct relationships compared to clustering based on drug response.
  • Identified specific gene-drug relationships, exemplified by 5-fluorouracil and L-asparaginase, linking transcript levels to drug sensitivity and resistance mechanisms.
  • Demonstrated the successful integration of large-scale gene expression and molecular pharmacology databases.

Conclusions:

  • Gene expression profiles provide a different perspective on cancer cell line relationships than drug response profiles.
  • The study establishes a framework for integrating transcriptomic and pharmacologic data to understand drug mechanisms.
  • This integrated approach offers valuable insights for optimizing cancer drug discovery and therapeutic strategies.

Related Concept Videos